Teriparatide - Latest Advances

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: October 23, 2025

Approach to premenopausal osteoporosis.

Journal: Current opinion in endocrinology, diabetes, and obesity

Published: October 12, 2025

Effective Oral Delivery of Teriparatide Using Organoclay-Polymethacrylate Nanocomposites for Osteoporosis Therapy.

Journal: Pharmaceutics

Published: October 09, 2025

Response to the letter regarding "Rethinking physical and cognitive frailty definitions in the JOINT-05 teriparatide sub-analysis".

Journal: Journal of bone and mineral metabolism

Published: October 08, 2025

PINP-guided osteoporosis treatment selection: methodological considerations for cut-off, endpoint, fracture confounding and teriparatide heterogeneity.

Journal: Bone

Published: October 08, 2025

Comment on "Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study".

Journal: Bone

Published: October 01, 2025

Filters

Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage.

Bonegraft Using Octacalcium Phosphate Collagen Composite with Teriparatide and Polylactic Acid Cage.

Optimizing Bone Health in the Treatment of Lumbar Spondylolisthesis.

Optimizing Bone Health in the Treatment of Lumbar Spondylolisthesis.

Sequence treatment of postmenopausal osteoporosis

Sequence treatment of postmenopausal osteoporosis

Recent Advances in Osteoporosis Therapeutics.

Recent Advances in Osteoporosis Therapeutics.

Author response to letter to the editor, "PINP-guided osteoporosis treatment selection: methodological considerations for cut-off, endpoint, fracture confounding and teriparatide heterogeneity".

Author response to letter to the editor, "PINP-guided osteoporosis treatment selection: methodological considerations for cut-off, endpoint, fracture confounding and teriparatide heterogeneity".

Author response to letter to the editor, "Comment on "Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study"".

Author response to letter to the editor, "Comment on "Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study"".

Romosozumab mitigates progression from radiological to symptomatic adjacent-level fractures compared to teriparatide.

Romosozumab mitigates progression from radiological to symptomatic adjacent-level fractures compared to teriparatide.

Approach to premenopausal osteoporosis.

Approach to premenopausal osteoporosis.

Effective Oral Delivery of Teriparatide Using Organoclay-Polymethacrylate Nanocomposites for Osteoporosis Therapy.

Effective Oral Delivery of Teriparatide Using Organoclay-Polymethacrylate Nanocomposites for Osteoporosis Therapy.

Response to the letter regarding "Rethinking physical and cognitive frailty definitions in the JOINT-05 teriparatide sub-analysis".

Response to the letter regarding "Rethinking physical and cognitive frailty definitions in the JOINT-05 teriparatide sub-analysis".

PINP-guided osteoporosis treatment selection: methodological considerations for cut-off, endpoint, fracture confounding and teriparatide heterogeneity.

PINP-guided osteoporosis treatment selection: methodological considerations for cut-off, endpoint, fracture confounding and teriparatide heterogeneity.

Comment on "Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study".

Comment on "Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study".